Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Kidney Transplant Recipients: full-pipeline trial registry
2 of 5 indexed Kidney Transplant Recipients trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Kidney Transplant Recipients: 5 US clinical trials tracked, 2 recruiting.
Kidney Transplant Recipients is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Allergy and Infectious Diseases (NIAID), running 2 of these trials.
Enrollment posture brief
Registry condition kidney-transplant-recipients
OPEN 2 | RECR 40% | LATE 2 | EARLY 3 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Kidney Transplant Recipients lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Kidney Transplant Recipients on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Kidney Transplant Recipients is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Kidney Transplant Recipients research.
National Institute of Allergy and Infectious Diseases (NIAID) accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Kidney Transplant Recipients trials plan to enrol fewer than 100 people.
Median target enrolment is 61 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.
-
Kidney Transplant Recipients research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients
Massachusetts General Hospital
NCT06751992
Pilot Trial of Supplemental Vitamin A and Nicotinamide
Rhode Island Hospital
NCT05702398
COVID-19 Protection After Transplant Pilot Study
National Institute of Allergy and Infectious Diseases (NIAID)
NCT04969263
Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients
University of Cincinnati
NCT01336296
COVID Protection After Transplant-Immunosuppression Reduction
National Institute of Allergy and Infectious Diseases (NIAID)
NCT05077254
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Kidney Transplant Recipients records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Kidney Transplant Recipients trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Kidney Transplant Recipients page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Kidney Transplant Recipients trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most Kidney Transplant Recipients trials on record, review their full trial history before evaluating a specific study. See National Institute of Allergy and Infectious Diseases (NIAID)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Kidney Transplant Recipients condition card totals 5 registered trials; most-linked intervention mRNA-1273 vaccine (Moderna); top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.